Skip to Main Content

Paper Details

Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019.
Mayo Clin Proc
4
2022
Author NameAffiliation
John C O'HoroMayo Clinic, USA Mayo Clinic Health System
Sidna M Tulledge-ScheitelMayo Clinic, USA Mayo Clinic Health System
Ravindra GaneshMayo Clinic, USA Mayo Clinic Health System
  • 1 - 3

Datasets

Release 1.2